Waldencast plc (WALD) is a Consumer Discretionary stock trading at $1.29 (as of 2026-08-21), with a market capitalization of $147.15M. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.
Waldencast Acquisition Corp. a skin care company, provides advanced skin care treatments. Its products are designed to help minimize the appearance of premature skin aging, skin damage, hyperpigmentation, acne, and sun damage primarily available through dermatologists, plastic surgeons, medical spas, and other skin care professionals. Its portfolio includes Obagi Medical that provides transformational skin care products formulated to minimize signs of skin aging, address dark spots, hyperpigmentation, fine lines, and wrinkles and to protect and enhance skin tone and texture; and Obagi Clinical that offers skin care products designed to prevent the early signs of skin aging. The company was founded in 1988 and is based in White Plains, New York.
Waldencast sells advanced skincare treatments (including Obagi Medical and Milk Makeup) aimed at reducing signs of premature skin aging, skin damage, hyperpigmentation, acne, and sun damage, mainly through dermatologists, plastic surgeons, medical spas, and other skin care professionals.
Waldencast’s profit engine is tied to demand coming from professional channels and core product strength, as shown by the importance of the Physician Dispensed Channel, Top 20 Core Products Percentage, plus the ability of its brands to generate attention through earned media and retail sell-through.
Business quality (Weak): The company appears to run a high gross margin skincare business, but the operating line is currently heavily loss-making, so investors typically need evidence that professional-channel strength and brand demand can scale into operating profitability.
| Price | $1.29 |
| Market Cap | $147.15M |
| Price / Book | 0.29 |
| Price / Sales | 0.39 |
| FCF Yield | -30.1% |
| Revenue (TTM) | $272.07M |
| Net Margin | -84.4% |
| Revenue Growth (YoY) | -0.7% |
| EPS Growth (YoY) | 415.4% |
| FCF Growth (YoY) | 40.9% |
| Altman Z-Score | -1.13 (distress) |
| Piotroski F-Score | 3/9 (weak) |
| Sector P/E (Consumer Discretionary) | 20.7 |
| Industry P/E (Consumer Goods) | 22.1 |
| Top Institutional Holder | Zeno Equity Partners LLP ($11.64M) |
| Institutional Holders Tracked | 10 |
| Sector | Consumer Discretionary |
| Industry | Consumer Goods |
| CEO | Michel Brousset |
| Employees | 335 |
| Country | US |
| IPO Date | 2021-05-12 |
Data as of 2026-08-21.
Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.